Neural crest cells and fetal alcohol spectrum disorders: Mechanisms and potential targets for prevention

Shao-Yu Chen1, Maharajan Kannan1

  • 1Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY 40292, USA; University of Louisville Alcohol Research Center, Louisville, KY 40292, USA.

PubMed

Insights

Prenatal alcohol exposure harms neural crest cells (NCCs), leading to fetal alcohol spectrum disorders (FASD). Understanding ethanol

Area of Science:

  • Developmental Biology
  • Neuroscience
  • Teratology

Background:

  • Fetal alcohol spectrum disorders (FASD) are preventable birth defects from prenatal alcohol exposure.
  • Neural crest cells (NCCs) are crucial for developing the nervous system and craniofacial structures.
  • Ethanol exposure during embryogenesis disrupts NCC development, causing FASD-related abnormalities.

Purpose of the Study:

  • To review the detrimental effects of ethanol on NCC induction, migration, differentiation, and survival.
  • To examine molecular mechanisms underlying ethanol-induced NCC dysfunction.
  • To highlight potential therapeutic strategies for mitigating ethanol's impact on NCCs and FASD.

Main Methods:

  • Literature review of existing research on ethanol's effects on NCCs.
  • Analysis of molecular pathways involved in ethanol-induced NCC dysfunction.
  • Synthesis of current knowledge on FASD pathogenesis related to NCCs.

Main Results:

  • Ethanol exposure significantly impairs NCC induction, migration, differentiation, and survival.
  • Molecular mechanisms include oxidative stress, altered gene expression, apoptosis, and epigenetic changes.
  • These disruptions in NCCs contribute to the diverse structural and functional deficits seen in FASD.

Conclusions:

  • Ethanol's adverse effects on NCCs are a key factor in FASD development.
  • Targeting molecular pathways affected by ethanol may offer therapeutic interventions.
  • Further research is needed to develop effective strategies for preventing and treating FASD.